Claim(permalink)
In August 2021, antibodies derived from a llama's blood were included in a formula given to research participants in a study that aimed to identify a new COVID-19 treatment.
Factors
veracity
Political Leaning
Sentiment
Date published
2021-08-26
Entities
MarsBiotechnologyBiologyJasonClinical trialPlaceboLlamaParamount NetworkNational Institutes of HealthReutersBrusselsProteinAntibodyBelgiumAustin Motor CompanyImmune systemThe New York TimesCenters for Disease Control and PreventionPandemicVaccineSevere acute respiratory syndrome coronavirus 2Xavier SaelensSingle-domain antibodyAlpacaGhent UniversityDosedSeven of Nine
